Atherosclerotic Cardiovascular Disease
Conditions
Brief summary
Patients who had an ASCVD event at an Intermountain hospital will be screened for eligibility to be randomized. Subjects who meet eligibility criteria will be randomized 1:1 to receive targeted care of their LDL-C through a pharmacist-driven management program or not. Patients may opt-out of receiving LDL-C management by the pharmacy team at any time. The purpose of this program is to increase the proportion of patients who achieve guideline-based recommendations of LDL-C levels of \<70 mg/dL by increasing statin and/or LLT adherence and LDL-C testing. Data collection as part of the study will continue until the last person randomized has had 1-year of follow-up.
Interventions
OTHERClinical Pharmacy Team
Patients will receive targeted care of their LDL-C through a pharmacist-driven management program.
OTHERUsual Care
Patient will receive usual care for their LDL-C management.
Sponsors
Intermountain Health Care, Inc.
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Male or female \>18 years of age 2. Receive follow-up care with Intermountain Health 3. Value-based patient (as defined in the EDW) 4. Documentation of an ASCVD diagnosis, by 1 of the following: * Coronary artery disease (Primary inpatient CAD diagnosis during index encounter; Primary inpatient MI diagnosis during index encounter; PCI during index encounter; or CABG during index encounter * Cerebrovascular accident (Primary inpatient ischemic stroke diagnosis during index encounter; Carotid endarterectomy during index encounter; or Carotid stent during index encounter) * Peripheral arterial disease (Bypass or percutaneous intervention during index encounter)
Exclusion criteria
1. Patient age \<18 years. 2. Receipt of or expected receipt of palliative care, expected discharge to hospice, or long-term care facility (i.e., skilled nursing facility). 3. Pregnant or lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients who achieve an LDL-C <70 mg/dL by 1-year. | 1 year |
Countries
United States
Contacts
Primary ContactKirk U Knowlton, MD
Outcome results
None listed